← SynDRA
OGLUFANIDE
SynDRA canonical compound SYN0033641 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | VEGFA |
|---|
| Mechanism of action | VEGF antagonist |
|---|
All known targets
Mechanisms of action (all sources)
Drug classes
- Adjuvants, Immunologic
- Angiogenesis Inhibitors
- Anti-Arrhythmia Agents
- Antidotes
Cross-references
Synonyms
- Oglufanida
- NSC-334073
- Glufanide disodium
- Oglufanide disodium
- IM-862
- Kaposis sarcoma therapy, Cytran
- Thymogen
- Glutamyltryptophan
- L-Tryptophan, L-alpha-glutamyl-
- alpha-Glu-Trp
- L-alpha-Glu-L-Trp
- oglufanida
- 4RHY598T5U
- NSC 334073
- NSC334073
- oglufanidum
- RefChem:167983
- DTXCID401353167
- H-Glu-Trp-OH
- Glu-trp
- L-glutamyl-L-tryptophan
- Oglufanide [INN]
- L-Glu-L-Trp
- L-alpha-Glutamyl-L-tryptophan
- MFCD00037953
- Timogen
- glutamyl-tryptophan
- IM 862 dipeptide
- UNII-4RHY598T5U
- CCRIS 8677
- EW dipeptide
- E-W Dipeptide
- L-Tryptophan, N-L-alpha-glutamyl-
- Thymogen(Oglufanide)
- Thymogen(Oglufanide)?
- OGLUFANIDE [WHO-DD]
- N-L-a-glutamyl-L-tryptophan
- Glutamate-Tryptophan dipeptide
- orb1299982
Look up OGLUFANIDE in the interactive SynDRA portal →